Cargando…
Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model
Parkinson’s disease is a neurodegenerative disorder, and no treatment has been yet established to prevent disease progression. Coenzyme Q10, an antioxidant, has been considered a promising neuroprotective agent; however, conventional oral administration provides limited efficacy due to its very low...
Autores principales: | Park, Hyung Woo, Park, Chun Gwon, Park, Min, Lee, Seung Ho, Park, Hye Ran, Lim, Jaesung, Paek, Sun Ha, Choy, Young Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293316/ https://www.ncbi.nlm.nih.gov/pubmed/32533070 http://dx.doi.org/10.1038/s41598-020-66493-w |
Ejemplares similares
-
Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
por: Martucci, Alessio, et al.
Publicado: (2019) -
Effect of Coenzyme Q10 on Radiation Nephropathy in Rats
por: Ki, Yongkan, et al.
Publicado: (2017) -
Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article
por: Bagheri, Shokufeh, et al.
Publicado: (2023) -
Coenzyme Q(10) Administration in Community-Acquired Pneumonia in the Elderly
por: Farazi, Aliasghar, et al.
Publicado: (2014) -
Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)